Chiasma, Inc. (CHMA) Stock Surged After Disclosure of Q1 2021 Financial Reports
Chiasma, Inc. (CHMA) stock prices were up by a marginal 0.24% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.22 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 4.27%, bringing it up to USD$4.40. Get the hottest stocks to […]
What’s Bringing Chiasma Inc. (CHMA) Stock Up 39.08% Premarket Today?
Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company, specializing to develop and commercialize oral drugs using transient permeability enhancer technology platform to reduce the burden of chronic injections and for the treatment of rare and severe conditions globally, announced entry into a definitive merger agreement to be acquired by Amryt Pharma plcin an all-stock combination, […]